Elite in Type 1 Diabetes (T1D)

Dr. Michael Haller

Pediatric Endocrinology
Florida Clinical Practice Association Inc
2001 Sw 13th St, Gi Clinic At Endoscopy Cen, 
Gainesville, FL 
Elite in Type 1 Diabetes (T1D)
Florida Clinical Practice Association Inc
2001 Sw 13th St, Gi Clinic At Endoscopy Cen, 
Gainesville, FL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Michael Haller is a Pediatric Endocrinologist in Gainesville, Florida. Dr. Haller is rated as an Elite provider by MediFind in the treatment of Type 1 Diabetes (T1D). His top areas of expertise are Type 1 Diabetes (T1D), Diabetic Ketoacidosis, Low Blood Sugar, and Type 2 Diabetes (T2D).

His clinical research consists of co-authoring 190 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 148 articles and participated in 5 clinical trials in the study of Type 1 Diabetes (T1D).

Graduate Institution
University Of Florida College Of Medicine
Specialties
Pediatric Endocrinology
Licenses
Pediatric Endocrinology in FL
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alliant Health
  • HMO
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
AvMed
  • HMO
  • POS
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Florida Blue
  • EPO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Options
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
Sunshine Health
  • EPO
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

FLORIDA CLINICAL PRACTICE ASSOCIATION INC
2001 Sw 13th St, Gi Clinic At Endoscopy Cen, Gainesville, FL 32608
Other Locations
FLORIDA CLINICAL PRACTICE ASSOCIATION INC
1549 Gale Lemerand Dr, Fl 4, Gainesville, FL 32610

Additional Areas of Focus

Dr. Haller has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Pediatric Growth Hormone Deficiency

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Multiple Ascending Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of NNC0361-0041 Administered Subcutaneously to Patients With Type 1 Diabetes Mellitus
A Multiple Ascending Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of NNC0361-0041 Administered Subcutaneously to Patients With Type 1 Diabetes Mellitus
Enrollment Status: Completed
Publish Date: May 20, 2025
Intervention Type: Other, Drug
Study Drugs: Pre-Proinsulin, TGF-Beta1, IL-10, IL-2
Study Phase: Phase 1
INHALE-1: A 26-week Primary Treatment Phase, With 26-week Extension, Open-label, Randomized Clinical Trial Evaluating the Efficacy and Safety of Afrezza® Versus Rapid-acting Insulin Analog Injections, Both in Combination With a Basal Insulin, in Pediatric Subjects With Type 1 or Type 2 Diabetes Mellitus
INHALE-1: A 26-week Primary Treatment Phase, With 26-week Extension, Open-label, Randomized Clinical Trial Evaluating the Efficacy and Safety of Afrezza® Versus Rapid-acting Insulin Analog Injections, Both in Combination With a Basal Insulin, in Pediatric Subjects With Type 1 or Type 2 Diabetes Mellitus
Enrollment Status: Completed
Publish Date: May 06, 2025
Intervention Type: Biological
Study Drugs: Afrezza, Rapid-acting Insulin Analog, Basal Insulin
Study Phase: Phase 3
Pancreas Volume in Preclinical Type 1 Diabetes
Pancreas Volume in Preclinical Type 1 Diabetes
Enrollment Status: Completed
Publish Date: April 13, 2023
Intervention Type: Procedure
A Prospective Randomized Placebo-Controlled Double Blind Clinical Trial to Evaluate the Safety and Efficacy of CLBS03 (Autologous Ex Vivo Expanded Polyclonal Regulatory T-cells) in Adolescents With Recent Onset Type 1 Diabetes Mellitus (T1DM)
A Prospective Randomized Placebo-Controlled Double Blind Clinical Trial to Evaluate the Safety and Efficacy of CLBS03 (Autologous Ex Vivo Expanded Polyclonal Regulatory T-cells) in Adolescents With Recent Onset Type 1 Diabetes Mellitus (T1DM)
Enrollment Status: Completed
Publish Date: January 08, 2021
Intervention Type: Biological
Study Phase: Phase 2
A Phase 3 Study to Evaluate the Glucose Response of G-Pen (Glucagon Injection) in Pediatric Patients With Type 1 Diabetes
A Phase 3 Study to Evaluate the Glucose Response of G-Pen (Glucagon Injection) in Pediatric Patients With Type 1 Diabetes
Enrollment Status: Completed
Publish Date: December 11, 2018
Intervention Type: Drug
Study Phase: Phase 3
View 4 Less Clinical Trials

190 Total Publications

Connecting the Spots: Serial Home C-peptide Measurements Paint an Accurate Picture of Change in β-Cell Function.
Connecting the Spots: Serial Home C-peptide Measurements Paint an Accurate Picture of Change in β-Cell Function.
Journal: Diabetes care
Published: June 02, 2025
Similar Doctors
Elite in Type 1 Diabetes (T1D)
Dr. Desmond A. Schatz
Pediatric Endocrinology
Elite in Type 1 Diabetes (T1D)
Dr. Desmond A. Schatz
Pediatric Endocrinology
1600 Sw Archer Rd, 
Gainesville, FL 
 (0.5 miles away)
352-273-9270
Languages Spoken:
English
See accepted insurances

Desmond Schatz is a Pediatric Endocrinologist in Gainesville, Florida. Dr. Schatz is rated as a Distinguished provider by MediFind in the treatment of Type 1 Diabetes (T1D). His top areas of expertise are Type 1 Diabetes (T1D), Diabetic Ketoacidosis, Type 2 Diabetes (T2D), and Low Blood Sugar.

Elite in Type 1 Diabetes (T1D)
Dr. Laura Jacobsen
Pediatric Endocrinology
Elite in Type 1 Diabetes (T1D)
Dr. Laura Jacobsen
Pediatric Endocrinology
1600 Sw Archer Rd, 
Gainesville, FL 
 (0.5 miles away)
352-334-1390
Languages Spoken:
English
See accepted insurances

Laura Jacobsen is a Pediatric Endocrinologist in Gainesville, Florida. Dr. Jacobsen is rated as a Distinguished provider by MediFind in the treatment of Type 1 Diabetes (T1D). Her top areas of expertise are Type 1 Diabetes (T1D), Diabetic Ketoacidosis, Type 2 Diabetes (T2D), and Low Blood Sugar.

Elite in Type 1 Diabetes (T1D)
Dr. Larry Fox
Pediatric Endocrinology
Elite in Type 1 Diabetes (T1D)
Dr. Larry Fox
Pediatric Endocrinology
807 Childrens Way, 
Jacksonville, FL 
 (62.0 miles away)
904-390-3600
Languages Spoken:
English
See accepted insurances

Larry Fox is a Pediatric Endocrinologist in Jacksonville, Florida. Dr. Fox is rated as a Distinguished provider by MediFind in the treatment of Type 1 Diabetes (T1D). His top areas of expertise are Type 1 Diabetes (T1D), Pediatric Growth Hormone Deficiency, Growth Hormone Deficiency (GHD), and Low Blood Sugar.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Haller's expertise for a condition
ConditionClose
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile